Glenmark Pharmaceuticals Inc., USA Viorele, Desogestrel and Ethinyl Estradiol, USP recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
The hazard: Potency, impurity or stability failure
An out-of-specification result prompted this notice — potency, an impurity, or stability over the shelf life.
What the notice says: Failed Impurities/Degradation Specifications
Why it matters: The product failed a specification test: it may contain more or less active ingredient than the label states, carry an impurity, or degrade before its expiry date. A sub-potent dose can leave a condition untreated; a super-potent one can cause an overdose.
Symptoms and when to call a doctor
The risk depends entirely on the drug. For a medicine where dose matters closely — a blood thinner, an anti-epileptic, a thyroid or heart medicine, insulin — talk to your prescriber before changing anything. Seek urgent care if you have symptoms that suggest too much drug, or if the condition the medicine controls starts breaking through.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0021-2026
- Published
- October 22, 2025
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Glenmark Pharmaceuticals Inc., USA
- Product type
- Prescription & OTC drugs
- Units affected
- 26,928 packs
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Batch number 20230733, Exp Date: October 2025
Products covered by this recall
Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Blisters each containing 28 Tablets, Rx only, 28 day Regimen, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430, NDC 68462-318-29.
Check your product
The notice names 8 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 20230733
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- October 2025 — 26
- 928 packs
NDC number
On the carton and again on the bottle or blister label.
- 68462-318-29
Package size
Match the net weight or the piece count on the front of the pack.
- 0.15 mg
- 0.02 mg
- 0.01 mg
- 928 packs
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Potency
Glenmark Pharmaceuticals Inc., USA — An out-of-specification result prompted this notice — potency, an impurity, or stability over the shelf life.
- Check the lot number on your pack against the codes listed above before you do anything else.
- Do not stop a prescription on your own. For most conditions an uncertain dose is safer than no dose while you get advice.
- Call your prescriber or pharmacist and ask whether to swap the lot, re-test, or change nothing.
- Keep the carton and the leaflet — the lot number is usually printed only on the outer pack.
What the company owes you
A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.
- The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
- Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
- Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
- Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.
Company contact: Glenmark Pharmaceuticals Inc., USA — 750 Corporate Dr, Mahwah, NJ, 07430-2009
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Glenmark Pharmaceuticals Inc., USA prescription & otc drugs recalled?
Failed Impurities/Degradation Specifications Failed Impurities/Degradation Specifications
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 20230733; best-by date October 2025 — 26 or 928 packs. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above before you do anything else.
Can I get my money back?
The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 3 months ago
Glenmark Pharmaceuticals Inc., USA Azelaic Acid Gel, 15%, 50 gram tubes recall: CGMP Deviations: Product quality complaints concerning abnormal texture
CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
-
Class II · 4 months ago
Glenmark Pharmaceuticals Inc., USA Alyacen 7/7/7 recall: Failed Impurities/Degradation Specifications: This recall is being initiated
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
-
Class II · 10 months ago
Glenmark Pharmaceuticals Inc., USA Ondansetron Orally Disintegrating Tablets recall: Defective container: Preferred Pharmaceuticals received a letter
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
-
Class III · 10 months ago
Glenmark Pharmaceuticals Inc., USA Nebivolol Tablets, 20 mg, 90 Tablets recall: Cross Contamination with Other Products
Cross Contamination with Other Products
-
Class III · 11 months ago
Glenmark Pharmaceuticals Inc., USA Bisoprolol Fumarate and Hydrochlorothiazide recall: Cross Contamination with Other Products: Testing of reserve samples showed
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
-
Class II · 1+ years ago
Glenmark Pharmaceuticals Inc., USA Azelaic Acid Gel, 15%, 50 grams recall: CGMP Deviations: Market complaints received for gritty texture (grainy)
CGMP Deviations: Market complaints received for gritty texture (grainy)